嘉和美康(688246.SH):2025年度净亏损2.53亿元

Core Viewpoint - Jiahe Meikang (688246.SH) reported a significant decline in revenue and net profit for the fiscal year 2025, primarily due to external economic factors and changes in healthcare funding policies [1] Financial Performance - The company achieved an operating revenue of 408 million yuan in 2025, a decrease of 31.13% compared to the previous year [1] - The net profit attributable to the parent company's owners was -253 million yuan, showing an improvement in losses by 3.34 million yuan year-on-year [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was -257 million yuan, with a reduction in losses of 4.28 million yuan compared to the previous year [1] Industry Impact - The reduction or delay in fiscal budget support from local governments for public hospitals' medical information construction has led to a compression or postponement of procurement demand from hospitals [1] - The deepening of medical insurance payment reforms has resulted in decreased revenue and profit margins for public hospitals, making them more cautious in using their own funds for software procurement [1] - The tightening of demand due to macroeconomic and policy influences has weakened customer purchasing intentions, contributing to the significant revenue decline for the company in 2025 [1]

GOODWILL-嘉和美康(688246.SH):2025年度净亏损2.53亿元 - Reportify